Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Malaghan Institute Finalist in the Wellington Gold Awards

Malaghan Institute Finalist in the Wellington Gold Awards


The Malaghan Institute of Medical Research is a finalist in the Wellington Gold Awards (Cyber Gold category).

Established in 1999, the annual Gold Awards are a showcase of organisational talent and capability and are a way of paying tribute to those who are building our community.

The Malaghan Institute’s Director, Professor Graham Le Gros says, “We’re delighted. This recognition validates all of our hard work to find better treatments for diseases like cancer and asthma and it reinforces our role in harnessing cutting edge technology to help beat diseases sooner.”

The Cyber Gold Award recognises innovation, leadership and sustained growth in the information sector.

The Malaghan Institute is New Zealand’s leading independent medical research institute. The Institute is focused on improving the quality of life of New Zealanders by harnessing the power of the immune system; the body’s own natural defence against disease.

Professor Graham Le Gros says, “We’ve been part of Wellington for almost 50 years and our goal has remained constant, to develop better treatments for people with diseases like cancer, asthma and allergic diseases. Like the Gold Awards, we’ve grown in reputation and outcomes. But this award is not about us. Patients need better solutions, fast. That's what we're aiming for.

“Modern medicine and technology are inseparable. The story of medical progress at the Malaghan Institute is one of excellence in technology. We use world–leading techniques like laser analysis of cells using Flow Cytometry to help accelerate the pace of our research.

“Our combination of knowledge, experience and technology creates the platform for success. In 2013 our achievements included the discovery of a unique type of immune cell in the skin, which impacts the development of allergic skin disease; the start of our Phase 1 clinical trial of a melanoma cancer immunotherapy and being part of global Cancer Immunotherapy effort recently recognised by the internationally renowned journal Science as the worldwide Scientific Breakthrough of 2013.

“We are particularly delighted to be recognised by the Gold Awards as it helps us demonstrate to our thousands of supporters throughout New Zealand that their generosity will help us beat diseases sooner. Medical research is challenging, but thanks to the support of people and organisations throughout New Zealand this is an era of great promise for immunotherapy."

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news